Drug Shortage Report for METHOTREXATE INJECTION BP

Last updated on 2024-04-26 History
Report ID 218309
Drug Identification Number 02464365
Brand name METHOTREXATE INJECTION BP
Common or Proper name METHOTREXATE (METHOTREXATE SODIUM)
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL
Packaging size 2ml
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-02-02
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-04-26
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-04-26 French Compare
v8 2024-04-26 English Compare
v7 2024-03-08 French Compare
v6 2024-03-08 English Compare
v5 2024-02-09 French Compare
v4 2024-02-09 English Compare
v3 2024-02-03 English Compare
v2 2024-02-02 French Compare
v1 2024-02-02 English Compare

Showing 1 to 9 of 9